Assessing acceptability and sexual behaviour during male contraception: mood, behavior and user's perspectives related to sperm suppression with norethisterone enanthate (NET-EN) plus testosterone undecanoate (TU) in normal me

Completed

• Conditions: Male contraception; Not Applicable; Contraception

• Registration Number: ISRCTN85103855
• Lead Sponsor: DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-04-01
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 90

Inclusion Criteria

Current inclusion criteria as of 10/09/2007:
Male participants were recruited according the the recruitment strategy, inclusion criteria and exclusion criteria outlined on page 13 of clinical protocol number 303923 NET-EN plus TU for male contraception The World Health Organization did not support the clinical trial, but sponsored this acceptability component.

Previous inclusion criteria:
Same as those for the protocol for the clinical evaluation of the safety and efficacy of the hormonal regimens. The clinical component is supported by the private sector and supported by the World Health Organization (WHO) Department of Reproductive Health and Research; therefore, we do not have access to the protocol.

Exclusion Criteria

Male participants were recruited according to the recruitment strategy, inclusion criteria and exclusion criteria outlined on page 13 of clinical protocol number 303923 NET-EN plus TU for male contraception The World Health Organization did not support the clinical trial, but sponsored this acceptability component.

Study & Design

• Study Type: Interventional
• Study Design: Not specified